—
"China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules" provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making.China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics (IVD) Market sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease.
China In-Vitro Diagnostics (IVD) – Segment Analysis:
Immunoassay has the highest market share in China IVD market, but after 2018 its market share will decline. China Microbiology Market has grown approximately 4 times in 2016 compared to its market value in 2007. China Molecular Testing Market is expected to grow almost five times in future from its present market. Contribution of Point of Care Testing (POCT) market is low compared to Hematology Market, Coagulation Market and Self Monitoring of Blood Glucose (SMBG) Market. Other segments such as Molecular testing, Clinical Chemistry and Microbiology are poised to be remarkable expansion in the near future. Roche is the leading company in the China IVD market.
BUY this report @ http://www.orbisresearch.com/contact/purchase/285999 .
Factors Driving the Growth of In-Vitro Diagnostics (IVD) in China:
Some of the key factors driving the growth of China IVD market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of hospitals and independent clinical laboratories.
China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules is the 5th edition report on In-Vitro Diagnostics by Renub Research. This presents a detailed account of In-Vitro Diagnostics Market, its 8 Segments Market, Companies In-Vitro Diagnostics Sales in China, Registration of In-Vitro Diagnostics in China.
Request a sample for this report @ http://www.orbisresearch.com/contacts/request-sample/285999 .
This 101 Page report with 36 Figures and 2 Tables studies the China IVD market from 6 view points:
• Market and Forecast
• Segment Wise Market & Forecast
• Development Environment & Regulatory Status in China IVD market
• Company Wise IVD Sales & Forecast
• Growth Drivers for China In-Vitro Diagnostics
• Challenges for China In-Vitro Diagnostics
China IVD Market – Segment Analysis (2007 – 2022):
1. Clinical Chemistry Market & Forecast
2. Immunoassay Market & Forecast
3. Hematology Market & Forecast
4. Coagulation Market & Forecast
5. Microbiology Market & Forecast
6. Molecular Testing Market & Forecast
7. Self Monitoring of Blood Glucose (SMBG) Market & Forecast
8. Point of Care Testing (POCT) Market & Forecast
China IVD – Companies Sales Analysis (2011 – 2022):
1. Roche Diagnostics
2. Sysmex Corporation
3. Mindray Medical International Limited
4. Shanghai Kehua Bio-Engineering Co. Ltd.
5. Abbott Laboratories
6. Others
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)
Major Points form TOC:
1. Executive Summary
2. China IVD Market & Market Share (2007 – 2022)
3. China IVD Companies Market Share (2011 – 2022)
4. China IVD Market by Segments (2007 – 2022)
5. Development Environment of Chinese IVD Industry
6. China: Health Insurance and Reimbursement Policies (New)
7. Registration of In Vitro Diagnostic Reagents in China
8. Medical Devices and Reagents Class Registration in China
9. China IVD Industry Drivers
10. China IVD Industry Challenges
11. China IVD Market – Company Sales Analysis (2011 – 2022)
12. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
About us:
Orbis Research (our website: www.orbisresearch.com) is the most comprehensive database of market-related research. Serious researchers from across the globe seeking up-to-date information on the latest market trends with in-depth analyses turn to Orbis Research. Our massive database boasts authentic reports published by leading authors and publications. Orbis’ highly motivated and expert in-house team undertakes rigorous screening of the credentials of publishers and authors before accepting their submissions. Such vetting is imperative for internal quality control.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +1 (214) 884-6817
Website: http://www.orbisresearch.com
Release ID: 200008
Google
RSS